Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

its $5-Mil. on the GT assay

ESS is looking for full USDOD Army grant funding

burn rate will drop to $1.2-Mil. per BF on last CC

but who actually knows - including management themselves?

way too many NDA's and not enough "financial model" guidance

AMBS will need partners for ELTO, ESS and GT

with LymPro going commercial, I'd expect a similar JV arrangement



however, they have a biforcated plan of spinning out the DX

or partnering it, or selling it, or or or ....

the Street is confused, as AMBS was, is and continues to be 'all over the place'